View in EDS HTML Full Text PDF Full Text

Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Authors: Trilla-Fuertes L; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain., Gámez-Pozo A; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain., Nogué M; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital de Granollers, Barcelona, Spain., Busquier I; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain., Arias F; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Radiotherapy Oncology Service, Complejo Hospitalario de Navarra, Navarra, Spain., López-Campos F; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Radiotherapy Oncology Service, Hospital Ramón y Cajal, Madrid, Spain., Fernández-Montes A; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Ruiz A; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain., Velázquez C; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain., Martín-Bravo C; Medical Oncology Service, Hospital Costa del Sol, Málaga, Spain., Pérez-Ruiz E; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain., Asensio E; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital General Universitario de Elche, Elche, Spain., Hernández-Yagüe X; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Instituto Catalán de Oncología-Girona, Girona, Spain., Rodrigues A; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain., Ghanem I; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain., López-Vacas R; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain., Hafez A; Biotechvana SL, Parque Científico de Madrid, Madrid, Spain., Arias P; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain., Dapía I; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain., Solís M; Bioinformatics Unit, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain., Dittmann A; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland., Ramos R; Genomics Unit, Parque Científico de Madrid, Madrid, Spain., Llorens C; Biotechvana SL, Parque Científico de Madrid, Madrid, Spain., Maurel J; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Campos-Barros Á; Institute of Medical and Molecular Genetics, IdiPAZ, Hospital Universitario La Paz/CIBERER Unit 753, ISCIII, Madrid, Spain., Fresno Vara JÁ; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain., Feliu J; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain.; Cátedra UAM-Amgen, Universidad Autónoma de Madrid, Madrid, Spain.
Source: Cancer [Cancer] 2023 Aug 15; Vol. 129 (16), pp. 2581-2592. Date of Electronic Publication: 2023 Apr 25.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0142
DOI:10.1002/cncr.34797